Massachusetts Senator Threatens to Claw Back Opioid Settlement Funds as Communities Leave Millions Unspent

Massachusetts State Senator John Velis issued an extraordinary ultimatum this week, threatening to claw back millions in opioid settlement funds from cities and towns that have failed to deploy the money even as the state's overdose crisis continues to claim lives. The warning follows a television investigation that revealed municipalities have spent less than 20 percent of the $115 million distributed to them since 2023, with some communities making questionable purchases while others let the funds sit untouched in municipal accounts.

"Enough's enough," Velis told reporters after reviewing the findings. "You have this pot of money for this issue. Spend it."

The Westfield Democrat, who has championed addiction treatment legislation throughout his tenure, said he is prepared to file legislation that would allow the state to reclaim unspent settlement dollars and redirect them to communities demonstrating both need and capacity to implement evidence-based interventions. The threat represents a rare escalation in the ongoing tension between state oversight and local control over the massive financial settlements reached with pharmaceutical manufacturers and distributors.

The Spending Gap

Since 2023, Massachusetts cities and towns have received $115 million in opioid settlement funds—money intended to address the devastation wrought by prescription painkiller manufacturers accused of fueling the addiction crisis through deceptive marketing and lax distribution controls. According to data obtained by the investigation, those same municipalities have spent just $19 million, leaving roughly $96 million unspent as the state recorded more than 2,300 overdose deaths in 2024 alone.

The disparity has grown increasingly difficult to justify as the settlement payments continue to flow. Massachusetts expects to receive approximately $1 billion in total settlement funds through 2039, with 40 percent directed to municipalities under formulas that allocate money based on population and overdose burden. The state-administered portion, by contrast, has seen significantly higher utilization rates, with officials spending roughly half of available funds on treatment expansion, naloxone distribution, and prevention programs.

Local officials have offered various explanations for the slow pace of municipal spending. Many smaller communities lack dedicated public health staff capable of designing and administering complex addiction services programs. Others cite the need for careful planning to ensure sustainable programming that will outlast the finite settlement payments. Some have pointed to restrictive federal guidelines that limit how the funds can be used, though those restrictions explicitly cover the full continuum of care from prevention through long-term recovery support.

Questionable Expenditures

The investigation uncovered more troubling patterns alongside the simple failure to spend. Some municipalities have directed settlement funds toward purchases that stretch the boundaries of the agreed-upon uses, including equipment and personnel only tangentially related to substance use disorder. While the specific items were not detailed in initial reporting, the pattern aligns with concerns raised by addiction advocates nationwide who have watched settlement money flow to general budget needs rather than targeted crisis response.

The phenomenon is not unique to Massachusetts. Across the country, local governments have faced criticism for using opioid settlement dollars to backfill existing budget gaps, fund law enforcement activities unrelated to addiction, or purchase equipment with no clear connection to the overdose crisis. Johns Hopkins University research has documented dozens of jurisdictions where settlement funds have been diverted to purposes that would have been funded through general revenue absent the pharmaceutical litigation windfall.

Massachusetts does not currently prohibit such supplantation, leaving advocates dependent on public pressure and political accountability to ensure the money serves its intended purpose. Senator Velis's threatened legislation would represent a significant shift toward state-level enforcement of settlement fund integrity.

The Legislative Threat

Velis has not yet filed formal legislation, but his public warning signals a willingness to challenge the local control principles that have governed settlement fund distribution since the first payments arrived in 2021. Any clawback mechanism would face significant legal and political hurdles, potentially triggering resistance from municipal associations and raising constitutional questions about the state's authority to reclaim funds already distributed to local governments.

The senator's leverage may lie less in actual legislative passage than in the pressure created by his public stance. Municipal officials facing the prospect of losing unspent funds may accelerate spending decisions that have languished in committee reviews and community input processes. Several mayors contacted by reporters indicated they would be reviewing their settlement fund allocations in light of Velis's comments.

"The goal isn't to punish communities," Velis emphasized. "The goal is to get resources to people who need them. If a town can't figure out how to do that, someone else should have the chance."

National Context

Massachusetts's struggles reflect a broader national pattern of uneven settlement fund deployment. New Mexico's state auditor reported this month that nearly half of local governments had failed to report any spending by mid-2025 despite receiving millions in settlement dollars. Kentucky's Center for Economic Policy found that 90 percent of funds distributed to local governments remained unspent three years after payments began. Maine, which has received $83 million and spent $33 million, has seen its own controversies over allocation decisions including a disputed school resource officer position funded with settlement money.

The delays come as the overdose crisis evolves rather than recedes. While national death totals have declined for three consecutive years, the emergence of medetomidine—a veterinary sedative now appearing in fentanyl supplies across multiple states—has created new medical challenges requiring adapted response strategies. The synthetic opioid supply continues to shift in potency and composition, demanding flexible and well-funded public health infrastructure.

Advocates argue that every month settlement funds sit unspent represents missed opportunities for prevention, treatment, and harm reduction interventions that could save lives. The Massachusetts Municipal Association, which represents local governments, has defended the deliberate pace of spending as necessary to ensure effective programming, but faces increasing pressure to demonstrate concrete results from the billions flowing into communities nationwide.

Senator Velis's ultimatum may prove to be the opening salvo in a broader legislative push to accelerate settlement fund deployment. Similar clawback provisions have been proposed in other states facing comparable deployment gaps, though none have yet been enacted. The coming months will test whether political pressure can overcome the administrative and political barriers that have slowed the translation of pharmaceutical litigation victories into on-the-ground crisis response.

For the thousands of Massachusetts families touched by addiction, the debate over unspent millions carries urgent personal stakes. Each day of delay means continued gaps in treatment capacity, limited naloxone availability, and missed opportunities for prevention education in schools and communities. Whether Velis's threatened legislation materializes or simply catalyzes faster local action, the confrontation has forced a long-overdue reckoning with the pace at which settlement funds are reaching the people they were meant to help.